Celcuity INC.
Targeted cancer therapies focused on the PAM pathway
Visit website ContactClaim & upgrade this listingContact details are protected Something wrong? Suggest a correction
Celcuity develops and commercializes targeted therapies for patients with breast cancer and other solid tumors involving the PI3K/AKT/mTOR pathway. Its medicine portfolio includes REVTORPYK (gedatolisib), and its clinical programs evaluate gedatolisib for breast and prostate cancer.
At a Glance
Celcuity INC. is an American manufacturer based in Minneapolis, MN.
- Where
- Minneapolis, MN
